Business news from Ukraine

INDAR PRODUCTION FACILITIES IN BRAZIL CERTIFIED UNDER GMP

21 March , 2016  

KYIV. March 21 (Interfax-Ukraine) – Private joint-stock company Indar (Kyiv), an insulin producer, has obtained GMP (Good Manufacturing Practice) certificate for its production facilities in Brazil.

The certificate was issued by the Brazilian Health Surveillance Agency (ANVISA).

A GMP is a system for ensuring that pharmaceutical products are consistently produced and controlled according to quality standards.

Indar supplies recombinant insulin in the form of finished pharmaceutical products (FPPs).

Indar was created under a resolution of the Cabinet of Ministers in 1997 under the aegis of Kyiv meat processing plant. In 2012, the state fully reinstated its control over the enterprise which it lost in 2008 when the state stake of 70.7% belonging to Ukrmedprom was sold to Storke Holdings Limited (Belize).

Indar in 2016 joined the Association Manufactures of Medications of Ukraine (AMMU).